Drug Profile
Research programme: needle-free intra-dermal polio vaccine - PharmaJet/Netherlands Vaccine Institute
Alternative Names: IPV - NVI; Salk IPVLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Netherlands Vaccine Institute
- Developer Netherlands Vaccine Institute; PharmaJet
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Poliomyelitis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Poliomyelitis in Netherlands (Intradermal)
- 06 Apr 2010 Preclinical trials in Poliomyelitis in Netherlands (Intradermal)